Stenoparib, an Inhibitor of Cellular Poly(ADP-Ribose) Polymerase, Blocks Replication of the SARS-CoV-2 and HCoV-NL63 Human Coronaviruses <i>In Vitro</i>

Nathan E. Stone(Northern Arizona University), Christopher T. French(Northern Arizona University), Ashley Jones(Northern Arizona University), Sierra A. Jaramillo(Northern Arizona University), Ken Ng(Northern Arizona University), Adam J. Vazquez(Northern Arizona University), Lora M. Versluis(Northern Arizona University), Haley E. Nunnally(Northern Arizona University), Erik W. Settles(Northern Arizona University), Roxanne Nottingham(Northern Arizona University), Paul Keim(Northern Arizona University), Steen Knudsen(MC2 Therapeutics (Denmark)), Jason W. Sahl(Northern Arizona University), David M. Wagner(Northern Arizona University), Madison Martz(Northern Arizona University), Marlee O. Raniere(Northern Arizona University), Katherine E. Zarn(Northern Arizona University)
mBio
January 18, 2021
Cited by 24


Related Papers